Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°£¾ÏÀÇ ¼úÀü °Ë»ç·Î¼­ CTAP, CTHA ¹× Lipiodol CTÀÇ À¯¿ë¼º Usefulness of Combined CTAP, CTHA and Lipiodol CT as a Preoperative Study of Hepatocellular Carcinoma

´ëÇѼÒÈ­±âÇÐȸÁö 1998³â 32±Ç 6È£ p.740 ~ 748
¼Ò¼Ó »ó¼¼Á¤º¸
À̼®È£ ÀÌÁØÇõ/°í±¤Ã¶/À̱ÔÅÃ/ÀÌÁ¾±Õ/ÀÌdz·Ä/±èÀçÁØ/¹é½Â¿î/ÀÌÁ¾Ã¶

Abstract

¿ä¾à
¸ñÀû : CTAP ¹× CTHA´Â °£³» ¼Ò°£¼¼Æ÷¾ÏÀ» ¹ß°ßÇϴµ¥ ¸Å¿ì ¿¹¹ÎÇÑ °Ë»ç ¹æ¹ýÀ¸·Î °£
³» Á¾¾ç°ú Ç÷°ü°úÀÇ »óÈ£°ü°è, Á¤È®ÇÑ °£³» Á¾¾çÀÇ ÇغÎÇÐÀû À§Ä¡ µî ¸Å¿ì ±ä¿äÇÑ Á¤º¸¸¦
¾òÀ» ¼ö ÀÖ´Ù. ÀÌ¿¡ ÀúÀÚ µîÀº CTAP, CTHA ¹× Lipiodol CT°¡ °£¾Ï ȯÀÚÀÇ ¼úÀü °Ë»ç·Î¼­
ÀÇ ÀÇÀÇ¿¡ ´ëÇÏ¿© ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý : ÀúÀÚ µîÀº 1996³â 4¿ùºÎÅÍ 1997³â 8¿ù±îÁö »ï¼º¼­¿ïº´¿ø¿¡¼­ ½Ç½ÃÇÏ¿´´ø
CTAP, CTHA ¹× Lipiodol CT Áß, ³ª¼±½Ä CT¿Í Ç÷°ü Á¶¿µ¼ú»ó ¿Ü°úÀû ÀûÃâÀÌ °¡´ÉÇÏ¿´°í
¼ö¼úÀ» ¸ñÀûÀ¸·Î ½ÃÇàÇÏ¿´À¸¸ç ¼úÀü Á¶Á÷ °Ë»ç·Î °£¾ÏÀÌ Áõ¸íµÇ¾ú°í Lipiodol CT·Î Ãß°¡Àû
Á¾¾ç °áÀýÀ» È®ÀÎÇÒ ¼ö ÀÖ¾ú´ø 82¿¹¸¦ ´ë»óÀ¸·Î ÇÏ¿´´Ù. ¾çÂÊ ´ëÅ𵿸ÆÀ» õÀÚÇÑ ÈÄ »óÀå°£
¸·µ¿¸Æ°ú ÃÑ°£µ¿¸Æ ȤÀº °íÀ¯°£µ¿¸Æ ±â½ÃºÎ¿¡ Ä«Å×Å͸¦ À§Ä¡ÇÏ°í ȯÀÚ¸¦ CT ¹æÀ¸·Î ¿Å°Ü
Á¶¿µÁ¦¸¦ ÁÖÀÔÇÏ¿© CTAPºÎÅÍ ½ÃÇàÇÑ ÈÄ CTHA¸¦ ½ÃÇàÇÏ¿´´Ù.
°á°ú : ³ª¼±Çü CT¿Í Ç÷°üÁ¶¿µ¼ú¿¡¼­ 105°³ÀÇ °áÀýÀ», CTAP ¹× CTHA¿¡¼­ 138°³ÀÇ °áÀý
À» ¹ß°ßÇÏ¿© 28%ÀÎ 23¿¹¿¡¼­ 33°³ÀÇ °áÀýÀ» Ãß°¡ÀûÀ¸·Î ¹ß°ßÇÒ ¼ö ÀÖ¾úÀ¸¸ç 12%ÀÎ 10¿¹¿¡
¼­ ¿Ü°úÀû Ä¡·á ¹æħ¿¡¼­ ºñ¿Ü°úÀûÀÎ Ä¡·á ¹æħÀ¸·Î Ä¡·á ¹æÇâÀÌ ¹Ù²î¾ú´Ù. Ä¡·á ¹æħÀÌ ¹Ù
²ï 10¿¹ Áß 11%ÀÎ 9¿¹´Â ÆíÃø¿±¿¡¼­ ¾çÃø¿±À¸·Î Á¾¾çÀÇ ÇغÎÇÐÀûÀÎ º´º¯ÀÌ È®´ëµÇ¾ú°í 1%
ÀÎ 1¿¹¿¡¼­´Â ÆíÃø¼ºÀÌÁö¸¸ °áÀýÀÌ 4°³ ÀÌ»óÀ¸·Î Áõ°¡ÇÑ °æ¿ìÀÌ´Ù. ¶ÇÇÑ ³ª¼±½Ä CT¿¡¼­ Á¾
¾çÀÇ Å©±â°¡ Ŭ¼ö·Ï CTAP¿Í CTHA¿¡¼­ Ãß°¡ Á¾¾ç °áÀýÀ» ¹ß°ßÇÒ È­·üÀÌ ³ô¾ÒÀ¸¸ç
(p=0.03), ³ª¼±½Ä CT¿¡¼­ÀÇ °áÀý °¹¼ö¿¡ µû¶ó CTAP¿Í CTHA¿¡¼­ Ãß°¡·Î °áÀýÀ» ¹ß°ßÇÒ
È®·üÀº Åë°èÇÐÀûÀ¸·Î Â÷ÀÌ°¡ ¾ø¾ú´Ù(p=0.84). Lipiodol CT¸¦ ½Ç½ÃÇÏ¿´´ø 27¿¹ Áß 6¿¹(22%)
¿¡¼­ CTAP ¹× CTHA¿¡¼­ °¢°¢ 6°³ÀÇ Ãß°¡ °áÀýÀ» ¹ß°ßÇÏ¿´°í 3¿¹(11%)¿¡¼­´Â °£¼¼Æ÷¾Ï
ÀÇ º´º¯ÀÌ ¾çÃø¿±À¸·Î È®´ëµÇ¾î ¿Ü°úÀû Ä¡·á ¹æħÀÌ ºñ¿Ü°úÀûÀÎ Ä¡·á ¹æħÀ¸·Î ¹Ù²î¾ú´Ù.
°á·Ð : CTAP, CTHA ¹× Lipiodol CT´Â ºÒÇÊ¿äÇÑ ¿Ü°úÀû ¼ö¼úÀ» ÇÇÇÒ ¼ö ÀÖ°Ô ÇÏ¿© ÁÖ´Â
µ¥ ¸Å¿ì À¯¿ëÇϸ®¶ó »ç·áµÇ¸ç CTAP, CTHA ¹× Lipiodol CTÀÇ Á¤È®ÇÑ ¿¹¹Îµµ ¹× ƯÀ̵µ¸¦
¾Ë±â À§ÇÏ¿©¼­´Â º´¸®¼Ò°ß°ú ºñ±³ÇÏ´Â ÀüÇâÀûÀÎ ¿¬±¸°¡ µÚµû¶ó¾ß Çϸ®¶ó »ý°¢µÈ´Ù.
#ÃÊ·Ï#
Background/Aims : Computed tomography during arterial portography (CTAP),
computed nomography during hepatic arteriography (CTHA) and Lipiodol CT are highly
sensitive methods to detect intrahepatic tumor, Their sensitivity and accuracy are over
90% and 85%, respectively. We evaluated the usefulness of CTAP, CTHA and Lipiodol
CT as a preoperative examination.
Methods : For eighty two patients with hepatocellular carcinoma which were considered
as the resectable on spiral CT and angiogram, CTAP and CTHA were performed. The
additional nodules on CTAP and CTHA were confirmed by Lipiodol CT.
Results : CTAP and CTHA could find additional nodules in 28% of the patients. The
treatment plan was changed from surgical to nonsurgical method in 12% of the patients.
The larger tumor nodules were on the spiral CT, the more additional tumor nodules
were found on CTAP and CTHA (p=0.03). The probability of finding additional nodules
on CTAP and CTHA is not related with the counts of tumor nodules on the spiral CT
(p=0.84). CTAP and CTHA could find additional nodules in 6 cases of 27 cases who
underwent Lipiodol CT. The treatment plan was changed to nonsurgical treatment in 3
cases by the results of CTAP and CTHA.
Conclusions : We concluded that CTAP, CTHA and Lipiodol CT are useful in avoiding
unnecessary operation.

CTAP; CTHA; Lipiodol CT; Hepatocellular carcinoma; CTAP; CTHA; Lipiodol CT; Hepatocellular carcinoma;

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS